Default company panoramic image

Lazure Scientific, Inc.

We have developed a revolutionary device to treat prostate cancer without life altering side effects (currently in human clinical trials).

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Issaquah, WA, USA
  • Currency USD
  • Founded December 2006
  • Employees 2
  • Website

Company Summary

Current prostate cancer treatments (surgery, radiation) result in extremely high rates of urinary incontinence and sexual side effects. Prostate cancer is the most common cancer in men with over 240K men diagnosed and over 30K deaths annually in the USA. A whole gland treatment, such as ours, without side effects would provide for an extremely significant competitive advantage over current treatments and would provide men a better option.


  • Default avatar
    Charles Hill
    President and CEO

    24+ years of business and executive management experience. Formerly with KPMG (CPA) and Pistol Creek Company (a privately held investment company). Designed and oversees all aspects of preclinical testing as well as human clinical trials. Selected, engaged, and oversees all regulatory and clinical trial management consultants. Develop and manage patent strategies and counsel. Work closely with engineering/design device development team.

  • Default avatar
    Joshua Hockett
    Chief Technology Officer

    10+ years of engineering and system design experience. Formerly with Synapse Product Development. Expert mechanical and electrical engineering specialist with extensive medical device development experience. Lead architect/designer for all preclinical and clinical devices. Oversees and engages all external engineering/design teams. Participates in physician and hospital staff training at clinical trial site locations.

  • Default avatar
    Dr. Paul Lange
    Chief Medical Advisor

    Dr. Lange graduated from Washington University Medical School and received his general surgery and urology training at the University of Rochester, Duke University and the University of Minnesota. In 1988, Dr. Lange moved to the University of Washington as Professor and Chairman of the Department of Urology, a position held for 19 years. Dr. Lange is extensively published and was formerly on the New England Journal of Medicine editorial board.


  • Default avatar
    Daren Nitz - General, Mike Rosato (Wilson Sonsini) - Patent
    Default avatar
    Rick Cooley - Clark Nuber PS

Previous Investors

  • Default avatar
    High Net Worth Individuals Only